alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 10.5




 








 


AMENDMENT TO


EMPLOYMENT AGREEMENT


 


WHEREAS, Derma Sciences, Inc. (“Employer”)
and Barry Wolfenson (“Employee”) are parties to that certain Employment Agreement dated as of March 8, 2012
(the “Agreement”).


 


WHEREAS, Employer and Employee desire to
amend the Agreement to remove Employee’s ability to receive severance benefits upon Employee’s voluntary termination
of employment within six months of the occurrence of a change in control of Employer.


 


NOW, THEREFORE, in consideration of the
recitals set forth above, and for other good and valuable consideration, the adequacy and sufficiency of which are hereby acknowledged,
Employer and Employee agree that the Agreement be amended as follows:


 


1.Section 7 of the Agreement is hereby
deleted in its entirety.


 


2.Sections 8, 9, 10 and 11 of the Agreement
are hereby re-numbered as Sections 7, 8, 9 and 10, respectively.


 


3.The second sentence of Section 7 of the Agreement is
hereby amended to read in its entirety as follows:


 


This Agreement is intended to comply with the requirements
of Section 409A of the Internal Revenue Code and the regulations thereunder (“Section 409A”).


 


4.Section 8 of
the Agreement (Option Exercise Extension) is hereby amended to read in its entirety as follows:


 


In the event that Employer, without cause, either terminates
Employee’s employment or fails to renew this Agreement upon expiration hereof, then the period to exercise any option to
purchase the securities of Employer of which Employee may be possessed shall be extended to the earlier to occur of (i) the expiration
thereof as set forth in the option instrument or (ii) the 10th anniversary of the original date of grant.


 


Except as set forth herein, all of the other provisions of the
Agreement shall remain in effect.


 


This amendment may be executed in one or more counterparts,
each of which shall be deemed an original and all of which together shall be considered one and the same agreement.


 


[SIGNATURE PAGE FOLLOWS]


 



    	 



    	 



    

 


 


 


IN WITNESS WHEREOF, the parties have signed
this amendment on the 20th day of December, 2012.


 










	 	 	DERMA SCIENCES, INC.
	 	 	 
	 		/s/    Edward J. Quilty
	 	 	By: Edward J. Quilty
Title: President and Chief Executive
Officer









	 	 	EMPLOYEE.
	 	 	 
	 		/s/     Barry Wolfenson
	 	 	Name: Barry Wolfenson



  








    	2
No. 248, Misc.

#### Boyd *v.*United States.

Petitioner *pro se.*

*Solicitor General Cox, Assistant Attorney General Miller*and *Beatrice Rosenberg*for the United States.

C. A. 9th Cir. Certiorari denied.
No. 501, Misc.

#### Hatschner *v.*United States.

Petitioner *pro se.*

*Solicitor General Cox, Assistant Attorney General Miller, Beatrice Rosenberg*and *Julia P. Cooper*for the United States.

C. A. 10th Cir. Certiorari denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE OPTEL,
INC. NINE MONTH PERIOD ENDED MAY 31, 1999 FINANCIAL STATEMENTS AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. (amounts in
thousands)
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          AUG-31-1999
<PERIOD-END>                               MAY-31-1999
<CASH>                                          35,507
<SECURITIES>                                    39,235
<RECEIVABLES>                                   15,974
<ALLOWANCES>                                   (2,435)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         377,930
<DEPRECIATION>                                (51,885)
<TOTAL-ASSETS>                                 574,734
<CURRENT-LIABILITIES>                                0
<BONDS>                                        420,005
<PREFERRED-MANDATORY>                          221,890
<PREFERRED>                                          0
<COMMON>                                            28
<OTHER-SE>                                   (130,539)
<TOTAL-LIABILITY-AND-EQUITY>                   574,734
<SALES>                                              0
<TOTAL-REVENUES>                                63,024
<CGS>                                                0
<TOTAL-COSTS>                                   29,223
<OTHER-EXPENSES>                                42,253
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              38,661
<INCOME-PRETAX>                               (69,396)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (69,396)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (69,396)
<EPS-BASIC>                                    (30.56)
<EPS-DILUTED>                                  (30.56)


</TABLE>
EXHIBIT 32.2

                   CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                               MARWICH II, LTD.
                      PURSUANT TO 18 U.S.D. SECTION 1350


In connection with the Annual Report of Marwich II, Ltd. (the "Company") on
Form 10-KSB for the fiscal year ended January 31, 2001, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
Michael Schumacher, President, Chief Financial Officer, and Treasurer,
certify, pursuant to 18 U.S.C. SS 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

     (1)  The Report fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



/s/ Michael Schumacher
Michael Schumacher
President, Treasurer, and Chief Financial Officer
November 15, 2004
From: kenbarnes9@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:09:05 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Ken Barnes

Nampa, ID 83686
From: Sbl123@aol.com

To: E-OHPSCA2713.EBSA

Subject: FYI

Date: Friday, August 12, 2011 4:50:08 PM

I join with the American Association of University Women (AAUW) in asking you to accept the

recommendations of the Institute of Medicine as pertain to coverage of preventive care under the

new health care law, and to reject any exemptions for “religious employers.” These preventive

services are a critical element of the new law and would provide countless women better access to

necessary health care.

While AAUW believes that “religious refusal” exemptions unjustly deny women access to

contraceptive services, others, driven by an ideological distaste for all contraceptive services, are

pushing the government to make exemptions even larger. Indeed, some groups are pushing for

the exemption to apply to religiously-run health providers, so hospitals with religious

affiliations would be exempt from the coverage requirement, even though they employ people of all

faiths and ideologies. If granted, this larger exemption would deny access to thousands of women

just because of where they work.

I urge you to ensure women have access to quality preventive care by accepting IOM’s

recommendations and rejecting the proposed religious refusal exemption provisions.

Thank you

sbl123@aol.com
From: Deborah Cook

To: E-OHPSCA2713.EBSA

Subject: No religious exemptions!

Date: Friday, August 12, 2011 9:57:43 AM

Please, please remove any "conscience clause" from the Affordable Care Act for dispensing

contraceptives. This just smacks of discrimination, and will place an undue burden for obtaining LEGAL

medication on women who are responsibly trying to NOT get pregnant. These religious conscience

clauses are going too far.

Debbie

Sent from my iPad
No. 100, Misc.

#### Jessie *v.*Reincke, Warden.

Supreme Court of Errors of Connecticut. Certiorari denied.
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

DANIEL SCOTT MUZZY,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 400 WAL 2016

Petition for Allowance of Appeal from 

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 15th day of February, 2017, the Petition for Allowance of Appeal

is DENIED.
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

      We consent to the incorporation by reference in the Registration Statement
[Form S-3 No. 333-68899] and in Amendment No. 1 to the Registration Statement
[Form S-3 No. 333-6131] and related Prospectus of Cover-All Technologies, Inc.
and subsidiaries for the registration of 2,500,000 and of 6,591,528 shares,
respectively, of its common stock of our report dated March 20, 2000, with
respect to the 1999, 1998 and 1997 consolidated financial statements and
schedule of Cover-All Technologies, Inc. and subsidiaries included in its Annual
Report [Form 10-K] for the year ended December 31, 1999.

      We also consent to the incorporation by reference in the Registration
Statement [Form S-8 No. 333-44119] pertaining to the 1995 Employee Stock Option
Plan, in the Registration Statement [Form S-8 No. 33-18243] pertaining to the
1982 Incentive Stock Option Plan and in the Registration Statement [Form S-8 No.
33-44270] pertaining to the 1991 Key Employee Stock Option Plan, the 1988 Non-
Employee Director Stock Option Plan and certain Non-Qualified Stock Option
Contracts, and in the related Prospectus of Cover-All Technologies, Inc. and
subsidiaries of our report dated March 20, 2000, with respect to the 1999, 1998
and 1997 consolidated financial statements and schedule of Cover-All
Technologies, Inc. and subsidiaries included in its Annual Report [Form 10-K]
for the year ended December 31, 1999.


                                        MOORE STEPHENS, P. C.
                                        Certified Public Accountants.

Cranford, New Jersey
April 14, 2000
[Federal Register Volume 88, Number 172 (Thursday, September 7, 2023)]
[Notices]
[Pages 61604-61605]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19262]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental and Craniofacial Research; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special

[[Page 61605]]

Emphasis Panel, Review of Small Research Grants (R03) for Secondary 
Data PARs.
    Date: October 17, 2023.
    Time: 12:30 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Dental and Craniofacial Research, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Aiwu Cheng, Ph.D., MD, Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, National Institute of Dental and Craniofacial Research, 
6701 Democracy Blvd., Bethesda, MD 20892, (301) 594-4859, 
<a href="/cdn-cgi/l/email-protection#43022a34366d202b262d24032d2a2b6d242c35"><span class="__cf_email__" data-cfemail="bdfcd4cac893ded5d8d3dafdd3d4d593dad2cb">[email protected]</span></a>.
    Name of Committee: National Institute of Dental and Craniofacial 
Research, Special Emphasis Panel; Review of Clinical Study 
Applications.
    Date: October 26, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Dental and Craniofacial Research, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Yun Mei, MD, Scientific Review Officer, 
Scientific Review Branch, National Institute of Dental and 
Craniofacial Research, National Institutes of Health, 6701 Democracy 
Boulevard, Bethesda, MD 20892, (301) 827-4639 <a href="/cdn-cgi/l/email-protection#dda4a8b3f3b0b8b49db3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="225b574c0c4f474b624c4b4a0c454d54">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

    Dated: August 31, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-19262 Filed 9-6-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>   1
                                                                  EXHIBIT 10.128

                  [PREFERRED EQUITIES CORPORATION LETTERHEAD]

                               September 2, 1997

Mego Mortgage Corporation
1000 Parkwood Circle, 5th Floor
Atlanta, GA 30339

Attention: James L. Belter, Executive Vice President

Re: Loan Program Sub-Servicing Agreement (the "Agreement") dated as of
    September 1, 1996 between Preferred Equities Corporation ("PEC") and Mego
    Mortgage Corporation ("MMC")

Gentlemen:

This letter serves to confirm our agreement that the present monthly servicing
fee of one-twelfth (1/12) of one-half (1/2) of one percent (0.50%) as set forth
in Article 4 of the Agreement is hereby modified and amended to be one-twelfth
(1/12) of four tenths (4/10) of one percent (0.40%) of the outstanding principal
balance of all loans being serviced on the first day of the prior month. This
change is effective as of September 1, 1997. It is further agreed that upon the
later to occur of (i) January 1, 1998 or (ii) the first day of the month
following the month in which the aggregate principal balance of all loans being
serviced by PEC for MMC is equal to or exceeds $1,000,000,000, the monthly
servicing fee shall thereafter be one-twelfth (1/12) of thirty-five one
hundredths (35/100) of one percent (0.35%). Except as modified hereby, all other
terms and conditions of the Agreement shall remain in full force and effect.

Please sign a copy of this letter in the space indicated below to indicate your
acceptance and approval of the foregoing.

                               Very truly yours,

                               PREFERRED EQUITIES CORPORATION

                               By: /s/ FREDERICK H. CONTE  
                                  --------------------------------------------
                                  Frederick H. Conte, Executive Vice President 

Accepted and approved as of this 2nd day of September, 1997.

MEGO MORTGAGE CORPORATION

By: /s/  JAMES L. BELTER
   -----------------------------------------
   James L. Belter, Executive Vice President
No. 188, Misc.

#### Woods *v.*Lowery.

*Lomax B. Lamb, Jr.*and *William H. Maynard*for petitioner.

*John R. Stivers*for respondent.

C. A. 5th Cir. Certiorari denied.
From: amml@frontiernet.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:16:10 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Beth Bisson

Trent, SD 57065
<PAGE>


                                                                    EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         Solely for the purpose of complying with 18 U.S.C. ss.1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned
Chief Financial Officer of Alliance Pharmaceutical Corp. (the "Company"), hereby
certify, based on my knowledge, that the Annual Report on Form 10-KSB of the
Company for the year ended June 30, 2006 (the "Report") fully complies with the
requirements of Section 13(a) of the Securities and Exchange Act of 1934 and
that information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date:  September 27, 2006





By: /S/ EDWARD C. HALL
    ------------------------------
    Edward C. Hall
    Chief Financial Officer


A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Alliance Pharmaceutical Corp. and
will be retained by Alliance Pharmaceutical Corp. and furnished to the
Securities and Exchange Commission or its staff upon request.
BLOCK FLOW DIAGRAM OF CUSTOMER

PRODUCTION



### ATTACHMENT FOUR-SANITIZED
EXHIBIT 32.2



inTEST CORPORATION



In connection with the Quarterly Report of inTEST Corporation (the "Company") on Form 10-Q for the period ending March 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Hugh T. Regan, Jr., Secretary, Treasurer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date:	May 12, 2006

/s/ Hugh T. Regan, Jr.
Hugh T. Regan, Jr.
Secretary, Treasurer and Chief Financial Officer
From: eck.mary11@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:04:59 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Mary Eck

Chicago, IL 60646